Abstract
One of the main clinical problems after liver transplantation and liver resections is hepatic dysfunction due to ischemia/reperfusion (RI) injury. Several strategies have been implemented to decrease the IR injury. Recent experimental studies have demonstrated protective effects in tissues with the use of sevoflurane metabolites, mainly related to the trifluorinated carbon (CF3) structura…